Jericho, New York, United States Besides them, we counted 2 critical employees of this fund in our database.
The important activity for fund was in 2019. The fund is generally included in 2-6 deals every year. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 5 - 10 millions dollars.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the InFocus Capital Partners, startups are often financed by National Institutes of Health, ExSight Ventures, Wolfpack Investor Network. The meaningful sponsors for the fund in investment in the same round are Hatteras Venture Partners, ExSight Ventures, Aju IB Investment. In the next rounds fund is usually obtained by Hatteras Venture Partners, ExSight Ventures, Correlation Ventures.
Among the most popular portfolio startups of the fund, we may highlight Alievio, ONL Therapeutics. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Medical. The fund has no exact preference in some founders of portfolio startups.
Related Funds
| Fund Name | Location |
| Abstraction Ventures | Louisiana, New Orleans, United States |
| AFTERSHARE.TV | - |
| Agilent Ventures | California, Palo Alto, United States |
| Arkam Ventures | - |
| Dayang Group | China, Dalian, Zhejiang |
| Dialog Semiconductor | England, Reading, United Kingdom |
| Glory Technology (H.K) Group Limited | - |
| GREYSTAR | Charleston, South Carolina, United States |
| Gruppo Bancario Credito Valtellinese | Italy, Palermo, Sicilia |
| JAFCO Group | - |
| Juren Chuangtou | China, Chongqing, Chongqing Shi |
| KIIT-TBI | Bhubaneswar Municipal Corporation, India, Odisha |
| Linkage Biosciences | California, San Francisco, United States |
| Lucent New Ventures Group | - |
| Pasadera Capital | San Antonio, Texas, United States |
| Pathena | Brazil, Rio Grande do Sul, Viamão |
| Soleria Capital | Bayern, Germany, Munich |
| Star Thrive Group | Beijing, Beijing, China |
| Sumitomo Corporation Europe Limited | England, London, United Kingdom |
| Vistaar Technologies | New Jersey, Parsippany, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Re-Vana Therapeutics | $13M | 30 Nov 2022 | Belfast, Northern Ireland, United Kingdom | ||
Stuart Therapeutics | $11M | 19 Mar 2021 | Florida, United States | ||
ONL Therapeutics | $46M | 22 Dec 2020 | Ann Arbor, Michigan, United States | ||
Re-Vana Therapeutics | $3M | 02 Jun 2020 | Belfast, Northern Ireland, United Kingdom | ||
Mojo Vision | $51M | 29 Apr 2020 | California, United States | ||
Galimedix Therapeutics | 01 Jan 2020 | Kensington, Maryland, United States | |||
Trefoil Therapeutics | $28M | 16 Jul 2019 | San Diego, California, United States | ||
Pr3vent | $1M | 12 Feb 2019 | Palo Alto, California, United States | ||
Qura | $1M | 03 Jul 2018 | Framingham, Massachusetts, United States |
– Stuart Therapeutics from Stuart, Florida develops peptide therapeutics for ophthalmic diseases.
– The company raised $11m in Series A funding.
– The round was led by InFocus Capital Partners, with participation from the Wisconsin Alumni Research Foundation (WARF), MiMo Capital and BioBrit.
– The proceeds from the round will fund Phase 2 clinical trials for the company’s proprietary reparative therapeutic candidate, ST-100.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Re-Vana Therapeutics | $13M | 30 Nov 2022 | Belfast, Northern Ireland, United Kingdom | ||
Stuart Therapeutics | $11M | 19 Mar 2021 | Florida, United States | ||
ONL Therapeutics | $46M | 22 Dec 2020 | Ann Arbor, Michigan, United States | ||
Re-Vana Therapeutics | $3M | 02 Jun 2020 | Belfast, Northern Ireland, United Kingdom | ||
Mojo Vision | $51M | 29 Apr 2020 | California, United States | ||
Galimedix Therapeutics | 01 Jan 2020 | Kensington, Maryland, United States | |||
Trefoil Therapeutics | $28M | 16 Jul 2019 | San Diego, California, United States | ||
Pr3vent | $1M | 12 Feb 2019 | Palo Alto, California, United States | ||
Qura | $1M | 03 Jul 2018 | Framingham, Massachusetts, United States |
